Skip to main content
AUPH logo

AUPH · Aurinia Pharmaceuticals Inc. · Analyst Estimates

Track AUPH — free
$14.70 -0.19 (-1.28%) At close · Nov 20 Play latest call Q4 2025 earnings call transcript
Market Cap
$1.97B
Shares
134.00M
Volume · Nov 20 1.34M Avg daily vol (3M) 864.89K

Analyst Estimates

Compare analyst forecasts for Aurinia Pharmaceuticals Inc. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Pull consensus estimates through the analyst estimates API or MCP →

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians. An EPS figure names its accounting basis, GAAP or Non-GAAP, where the capture records one, and compares only with the company's EPS on that basis; without one, the basis is not recorded.

Captured 2026-11-21 06:25 UTC · Publication dates shown per estimate · 8 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD · Non-GAAP
Publication date not stated
0.93
0.97
1.00
5
0.95
0.94
0.94
0.95
2
2
2
2
Revenue
USD
Publication date not stated
329.00M
330.13M
331.31M
5
— — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD · Non-GAAP
Publication date not stated
0.68
1.16
1.63
5
1.17
1.07
1.07
1.11
3
4
1
1
Revenue
USD
Publication date not stated
360.00M
385.69M
461.12M
6
— — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD · Non-GAAP
Publication date not stated
0.17
0.21
0.24
5
0.21
0.20
0.20
0.23
2
2
1
2
Revenue
USD
Publication date not stated
84.38M
85.52M
86.68M
5
— — — — — — — —

Q ending 2027-03-31

Analyst estimates for Q ending 2027-03-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD · Non-GAAP
Publication date not stated
0.17
0.19
0.21
2
0.19
0.17
0.17
0.00
0
0
0
0
Revenue
USD
Publication date not stated
80.90M
82.95M
85.00M
2
— — — — — — — —
Key facts CIK 1600620 CUSIP 05156V102 13F (30d) 285 filings 254 filers Visit website Investor relations